ArticleDisease markers2022

Actin-Binding LIM 1 (ABLIM1) Inhibits Glioblastoma Progression and Serves as a Novel Prognostic Biomarker.

Danping Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.